Orgenesis Inc. (NASDAQ: ORGS)
$0.71
+0.0099 ( +1.41% ) 38.6K
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.
Market Data
Open
$0.71
Previous close
$0.70
Volume
38.6K
Market cap
$33.05M
Day range
$0.70 - $0.74
52 week range
$0.25 - $1.31
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jul 12, 2024 |
8-k | 8K-related | 14 | Jul 12, 2024 |
8-k | 8K-related | 13 | Jul 09, 2024 |
8-k | 8K-related | 14 | Jul 08, 2024 |
8-k | 8K-related | 14 | Jun 27, 2024 |
8-k | 8K-related | 13 | Jun 11, 2024 |
8-k | 8K-related | 36 | May 31, 2024 |
8-k | 8K-related | 17 | May 23, 2024 |
10-q | Quarterly Reports | 66 | May 20, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |